Szentiamide, an N-formylated cyclic depsipeptide from Xenorhabdus szentirmaii DSM 16338T

Natural Product Communications

Volumn 6, Issue 9, 2011, Pages 1247-1250

  Ohlendorf, Birgit ^a   Simon, Sven ^a,b   Wiese, Jutta ^a   Imhoff, Johannes F ^b  

^a GEOMAR HELMHOLTZ CENTRE FOR OCEAN RESEARCH KIEL   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Cyclodepsipeptide; Formylated; Xenorhabdus

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DEPSIPEPTIDE; PROTEIN TYROSINE PHOSPHATASE 1B; SZENTIAMIDE; UNCLASSIFIED DRUG; XENOFURANONE A; REPRESSOR PROTEIN; ZNF589 PROTEIN, HUMAN;

AMINO ACID ANALYSIS; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BROTH DILUTION; CARCINOMA CELL; CONTROLLED STUDY; DERIVATIZATION; DRUG CYTOTOXICITY; DRUG HYDROLYSIS; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; XENORHABDUS; XENORHABDUS SZENTIRMAII; CHEMICAL STRUCTURE; CHEMISTRY;

BACTERIA (MICROORGANISMS); XENORHABDUS; XENORHABDUS SZENTIRMAII;

DEPSIPEPTIDES; MOLECULAR STRUCTURE; REPRESSOR PROTEINS; XENORHABDUS;

EID: 80155169062     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1100600909     Document Type: Article

References (15)

1. (a) Lengyel K, Lang E, Fodor A., Szállás E, Schumann P, Stackebrandt E. (2005) Description of four novel species of Xenorhabdus, family Enterobacteriaceae: Xenorhabdus budapestensis sp. nov., Xenorhabdus ehlersii sp. nov., Xenorhabdus innexi sp. nov., and Xenorhabdus szentirmaii sp. nov. Systematic and Applied Microbiology, 28, 115-122;
2. (b) Bode HB. (2009) Entomopathogenic bacteria as a source of secondary metabolites. Current Opinion in Chemical Biology, 13, 224-230;
3. (c) Bowen D, Rocheleau TA., Blackburn M, Andreev O, Golubeva E, Bhartia R, ffrench-Constant RH. (1998) Insecticidal toxins from the bacterium Photorhabdus luminescens. Science, 280, 2129;
4. (d) Brown SE, Cao AT, Hines ER, Akhurst RJ, Easte PD. (2004) A novel secreted protein toxin from the insect pathogenic bacterium Xenorhabdus nematophila, The Journal of Biological Chemistry, 15, 14595-1460;
5. (e) Lang G, Kalvelage T, Peters A, Wiese J, Imhoff JF. (2008) Linear and cyclic peptides from the entomopathogenic bacterium Xenorhabdus nematophilus. Journal of Natural Products, 71, 1074-1077;
6. (f) Li J, Hu K, Webster JM. (1998) Antibiotics from Xenorhabdus spp. and Photorhabdus spp. (Enterobacteriacea) (Review). Chemistry of Heterocyclic Compounds, 34, 1331-1339. (Pubitemid 128698396)
7. (a) Brachmann AO, Forst S, Furgani GM, Fodor A, Bode HB. (2006) Xenofuranones A and B: phenylpyruvate dimers from Xenorhabdus szentirmaii. Journal of Natural Products, 69, 1830-1832;
8. (b) Demain AL, Fang A. (2000) The natural functions of secondary metabolites. Advances in biochemical Engineering/ Biotechnology, 69, 1-33;
9. (c) Li J, Chen G, Webster JM. (1995) Antimicrobial metabolites from a bacterial symbiont. Journal of Natural Products, 58, 1081-1086.
10. (a) Gualtieri M, Aumelas A, Thaler J. (2009) Identification of a new antimicrobial lysine-rich cyclolipopeptide family from Xenorhabdus nematophila. Journal of Antibiotics, 62, 295-302;
11. (b) Imhoff JF, Lang G, Kajahn I, Peters A, Wiese J. (2009) Herstellung und Verwendung antitumoraler, antibiotischer und insektizider Cyclodepsipeptide. Patent DE 10 2009 025 119 A1.
12. Bode HB. (2010) Insektenpathogene Bakterien als Quelle neuer Naturstoffe. Biospektrum, 16, 266-269.
13. Schoenafinger G, Schracke N, Linne U, Marahiel MA. (2006) Formylation domain: an essential modifying enzyme for the nonribosomal biosynthesis of linear gramicidin. Journal of the American Chemical Society, 128, 7406-7407. (Pubitemid 43877491)
14. Schneemann I, Kajahn I, Ohlendorf B, Zinecker H, Erhard A, Nagel K, Wiese J, Imhoff JF. (2010) Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea. Journal of Natural Products, 73, 1309-1312;
15. (b) Baki A., Bielik A, Molnár L, Szendrei G, Keserü GM. (2007) A high throughput luminescent assay for Glycogen Synthase Kinase-3β Inhibitors. ASSAY and Drug Development Technologies, 5, 75-83. (Pubitemid 46581242)